New IL-15 receptor-α splicing variants identified in intestinal epithelial Caco-2 cells
Author(s) -
Escudero-Hernández Celia,
Martínez-Abad Beatriz,
Ruipérez Violeta,
Garrote José A,
Arranz Eduardo
Publication year - 2017
Publication title -
innate immunity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.921
H-Index - 69
eISSN - 1753-4267
pISSN - 1753-4259
DOI - 10.1177/1753425916674263
Subject(s) - immune system , rna splicing , biology , caco 2 , cytokine , receptor , microbiology and biotechnology , inflammatory bowel disease , alternative splicing , intestinal epithelium , messenger rna , immunology , disease , gene , epithelium , cell culture , medicine , genetics , rna
IL-15 is a pleiotropic cytokine related to IL-2 which acts at a broader level than its counterpart. It is presented through its specific high-affinity receptor, IL-15Rα. Both cytokine and receptor are tightly regulated at multiple levels and are widely distributed. Thus, deregulation of their expression leads to an inflammatory immune response. Variants of splicing of IL-15Rα have been described in immune and barrier cells; however, their presence has not been focused on intestinal epithelial cells. In this study, we describe five new alternative variants of splicing of IL-15Rα in Caco-2 cells. Four of them were expressed into proteins inside Caco-2 cells, but these were unable to bind IL-15 or to follow the secretory pathway. However, the expression of mRNA itself might be relevant to diseases such as celiac disease, inflammatory bowel disease or colorectal cancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom